• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Comparative Genomic Hybridization of Human Lung Cancer

        互联网

        472
        Lung cancer is a highly aggressive neoplasm, a characteristic that is reflected by the multitude of genetic aberrations detectable on the chromosomal and molecular level. In order to understand these seemingly chaotic chromosomal alterations, we have performed Comparative Genomic Hybridization (CGH) on a large collective of human lung carcinomas. CGH was one of the first screening methods used to analyze tumor genomes for genetic imbalances (1 ,2 ), and has rapidly become a popular tool for a comprehensive molecular cytogenetic analysis of solid tumors. The method is based on the hybridization of differentially labeled tumor and reference DNA on normal chromosome metaphase spreads. Both genomes compete for complementary binding sites on the chromosomal DNA. In the case of an amplification in tumor DNA, more DNA will hybridize to the corresponding band or chromosomal arm, whereas deletions will allow the binding of the normal DNA to competitively prevail. Detection of each genome is facilitated by the use of distinct fluorochrome labels. DNA imbalances are determined by comparing the intensity of the fluorescence signals along individual chromosomes. DNA gains are potentially associated with the activation of proto-oncogenes and DNA losses with the inactivation of tumor-suppressor genes.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序